Boomerang Medical, Inc.

About Boomerang Medical, Inc.

Boomerang Medical is a women-led bioelectronic medicine company focused on disrupting the treatment of autoimmune diseases, particularly Inflammatory Bowel Disease (IBD) such as Crohn's disease and ulcerative colitis. Their mission is to advance treatment through innovative neuromodulation technology.

Products & Services

Bioelectric Neuromodulation Technology:A technology granted Breakthrough Device Designation by the FDA for treating Crohn's disease and ulcerative colitis, currently under evaluation in an FDA-approved clinical trial for ulcerative colitis at leading IBD centers in the US.

Specialties

Bioelectronic Medicine Neuromodulation Inflammatory Bowel Disease (IBD) Treatment Autoimmune Disease Treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 20000000 MR: - FA: 20 million FAN: 20000000	D: 2025-09-04 FD: 2025-09-04	2 investors

Series B Latest

2025-09-04

$20.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

H

Heather Simonsen

President & Chief Executive Officer

LinkedIn (Pro only)

D

David Miller

Co-Founder, Chief Innovation + Technology Officer

LinkedIn (Pro only)

L

Lucas Payne

Vice President, Therapy Development

LinkedIn (Pro only)

C

Colleen Holthe

Vice President, Clinical Affairs

M

Malea D'Amico

Senior Director, Clinical Therapy Development

M

Mariela Baughman

Director, Finance

View 15 more team members with Pro

Unlock Full Team Directory

Recent News